IFNA1 and neurodegenerative disease: Interestingly, an additional modulator of clinical symptoms has been hypothesized in neurodegenerative diseases – IFN indirectly promotes NMDA receptor activation, a possible driver of neurotoxicity and worsening symptoms (123).